SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Leerink Partners Cuts Mirum Pharmaceuticals Price Target to $140 From $154

Valid market news retained in the public archive without immediate LiveCast distribution.

MIRM

Related stories